In particular, immunofluorescence and Western blot analysis performed on spleen samples revealed increased pro-inflammatory ‘classically-activated’ macrophages in vehicle-treated 3xTg-AD mice, identified by the macrophage marker CD86. The gene discussed is CD86; the disease is Alzheimer disease.